- The University of Chicago (A.B., 2010)
- The George Washington University Law School (J.D., 2013)
- District of Columbia and Virginia
- United States District Court for the District of Columbia
- Novartis obtains summary judgment based on Daubert exclusion of causation expertsâ€™ testimony in ReclastÂ® case.
Jones v. Novartis Pharmaceuticals Corp., No. 2:13-cv-00624-VEH, 2017 WL 553134 (N.D. Ala. Feb. 10, 2017)
Catherine E. Stolar practices in the Firm’s Complex Litigation, Pharmaceutical Products, and Toxic Torts & Products Liability groups. She regularly defends manufacturers against products liability, environmental, and breach of contract claims in matters before state and federal courts across the country. In her time at the Firm, Ms. Stolar has defended Firm clients against hundreds of personal injury claims associated with pharmaceutical products in federal multidistrict litigation and state court consolidated proceedings. She has also counseled manufacturers on issues related to Superfund, hazardous waste, and natural resource damages.
Ms. Stolar has extensive experience in all aspects of pre-trial litigation, from conducting initial fact discovery to drafting trial examination outlines. She has authored a variety of successful dispositive motions and briefs, including motions for summary judgment and Daubert motions to exclude expert testimony, as well as motions on evidentiary and procedural issues. She has also taken numerous depositions, having deposed both fact and corporate witnesses.
Due to the highly technical and scientific nature of her caseload, Ms. Stolar routinely works with expert witnesses to develop case-specific opinions and prepares expert witnesses to provide testimony at deposition and trial. She has assisted in the defense and taking of expert depositions while at the Firm.
Ms. Stolar is a member of the Firm’s Recruitment committee and is active in the Firm’s pro bono program.